Suppression of NF-κB through adenoviral delivery of a modified form of IκBα markedly sensitizes chemoresistant tumors to the apoptotic potential of tumor necrosis factor-α and the chemotherapeutic compound CPT-11, resulting in tumor regression [30]. This evidence concerns the gene NFKBIA and neoplasm.